News
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
Parkinson’s UK and members of the Parkinson’s community attended the largest nationwide Party conferences to urge action to improve care and support for people with the condition.
HER-096, a potential new Parkinson's treatment, has shown promising phase 1 trial results, proving it’s safe, well-tolerated, and effective in reaching the brain in people with Parkinson's. This is a crucial step towards a drug that could slow, stop, or even repair Parkinson's damage.
Today, as the UK government launches its consultation to inform its new 10 year plan for the NHS workforce for England. We've outlined the vital changes needed to make sure people with Parkinson’s can access the care they need.
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.
Thanks to our crucial funding, a new drug treatment, created by NRG Therapeutics, is moving forwards.
Parkinson's UK is supporting a new national accreditation for exercise professionals.
We’re calling on the Scottish government to protect social security and invest in mental health services.
Local campaigners across England have been busy speaking to MPs and councillors, and holding events to raise awareness of Parkinson’s and help improve services and support.
We're partnering with Oxford Mindfulness to help people living with Parkinson's across the UK get access to physical activity, wellbeing and mindfulness resources.